Artemis Bioservices (formerly known as Artemis Bio-Support)
Dr. Sudip Kumar Dutta is currently working as a Study Director and Principal Investigator at Artemis Bioservices (formerly known as Artemis Bio-Support) since August 2022. Prior to this, Dr. Dutta held the position of Innovation Scientist at Artemis One Health since March 2019. With a background in life science and biotechnology, Dr. Dutta completed a Doctor of Philosophy (PhD) at the School of Tropical Medicine in India. Before joining the industry, Dr. Dutta gained research experience as a Research Fellow at the Calcutta School Of Tropical Medicine from April 2011 to February 2019. His expertise lies in understanding virus host pathogenesis through in-silico and in-vitro methods.
Artemis Bioservices (formerly known as Artemis Bio-Support)
Artemis Bioservices is a private, non-profit CRO specialized in vaccine and antiviral evaluation. Vision of Artemis Bioservices: The vision of Artemis Bioservices is to become a strategic partner in the process of antiviral, antibody and vaccine development against emerging viral diseases. Mission of Artemis Bioservices: To assist biotech and biopharmaceutical companies to accelerate the development and licensing of safe and effective antiviral intervention strategies, in particular against emerging, zoonotic and arboviral diseases, by offering customized in-vitro testing and in-vivo immunogenicity and efficacy testing capabilities Artemis Bioservices provides high quality preclinical and clinical services to developers of antiviral intervention strategies who want to evaluate the immunogenicity and efficacy of candidate products, especially against emerging, vector-borne and zoonotic viruses. Artemis Bioservices has recently been certified GLP compliant. Artemis Bioservices is located in the Yes!Delft Labs building, at Molengraaffsingel 10, 2629 JD, Delft, The Netherlands.